Location of Repository

The proteomics in prostate cancer biomarker discovery

By V. E. Shevchenko, A. V. Olenich and N. E. Olenich

Abstract

<p>Prostate cancer (PC) represents the second most frequent type of tumor in men worldwide. Proteomics represents a promising approach for the discovery of new biomarkers able to improve the management of PC patients. Markers more specific and sensitive than prostate-specific antigen are needed for PC diagnosis, prognosis and response to treatment. Moreover, proteomics could represent an important tool to identify new molecular targets for PC tailored therapy. Now several possible PC biomarkers sources, each with advantages and limitations, are under investigation, including tissues, urine, serum, plasma and prostatic fluids. Innovative high-throughput proteomic platforms are now identifying and quantifying new specific and sensitive biomarkers for PC detection, stratification and treatment. Nevertheless, many putative biomarkers are still far from being applied in clinical practice.</p><p>This review aims to discuss the recent advances in PC proteomics, emphasizing biomarker discovery and their application to clinical utility for diagnosis and patient stratification.</p

Topics: рак предстательной железы, протеомика, биомаркеры, масс-спектрометрия, опухолевая ткань, жидкости организма, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Publisher: ABV-press
Year: 2015
OAI identifier: oai:doaj.org/article:6d56563848114ae68e840bbcbb7e4b63
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2413-3787 (external link)
  • https://doaj.org/toc/2313-805X (external link)
  • http://umo.abvpress.ru/jour/ar... (external link)
  • https://doaj.org/article/6d565... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.